Anchor Therapeutics
Research - Cambridge, Massachusetts, United States
Anchor Therapeutics Employees
Anchor Therapeutics Details
Anchor Therapeutics is pioneering a new class of drugs called Pepducins. Pepducins are a breakthrough approach to targeting and allosterically modulating G-protein coupled receptors (GPCRs) on the inside surface of the cell membrane. GPCRs are critically involved in a wide variety of serious illnesses, including diabetes, inflammation, cancer, CNS disorders and cardiovascular disease. Pepducin technology represents an exciting new area of research directed towards a well-validated class of drug targets including orphan and intractable targets.
Website:
http://www.anchortx.com
Employees:
4
HQ:
+1 617-715-1999
Location:
Cambridge, Massachusetts, United States
Revenue:
29.0M
Anchor Therapeutics Technologies
Load Balancers
Apache